Format

Send to

Choose Destination
Clin Biochem. 2012 Oct;45(15):1192-6. doi: 10.1016/j.clinbiochem.2012.05.025. Epub 2012 May 31.

Gamma-glutamyltransferase, alanine transaminase and aspartate transaminase levels and the diagnosis of gestational diabetes mellitus.

Author information

1
Department of Obstetrics & Gynecology, University of Malaya, Lembah Pantai, Kuala Lumpur 50603, Malaysia. pctan@um.edu.my

Abstract

OBJECTIVES:

To evaluate gamma-glutamyltransferase (GGT), alanine transaminases (ALT) and aspartate transaminases (AST) levels and prevalent gestational diabetes mellitus (GDM).

DESIGN AND METHODS:

Random plasma glucose, GGT, ALT and AST and the 50-g glucose challenge test were done on antenatal women followed by diagnostic 3-point 75-g oral glucose tolerance test within two weeks. GDM was diagnosed by ADA (2011) criteria.

RESULTS:

The GDM rate was 12.2% (319/2610). Mean GGT level was higher in GDM women, 18 ± 12 vs. 16 ± 11 IU/L; P=0.03. The risk for GDM was higher for women in the highest GGT quartile band compared to the lowest: RR 1.35 95%CI 1.0-1.8; P=0.04. However, after adjustment for confounders, GGT was no longer associated with GDM. There was no correlation between ALT and AST levels and GDM.

CONCLUSIONS:

Liver transaminases do not predict GDM in contrast to type 2 diabetes.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center